Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1988-12-30
1990-08-28
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514530, 514573, 514913, A61K 31535, A61K 31215, A61K 3119
Patent
active
049525816
ABSTRACT:
This invention provides a method for treating ocular hypertension or glaucoma in a subject's eye. The method comprises contacting the surface of the eye with an effective intraocular pressure reducing amount of a mixture of an adrenergic blocking agent and a prostaglandin or prostaglandin derivative in an ophthalmically compatible carrier, so as to reduce the intraocular pressure of the eye and maintain such reduced intraocular pressure.
This invention also provides a composition for topical treatment of ocular hypertension or glaucoma in the eye of a subject. The composition comprises an effective intraocular pressure reducing amount of a mixture of an adrenergic block agent and a prostaglandin or prostaglandin derivative in an ophthalmically compatible carrier.
REFERENCES:
patent: 4474751 (1984-10-01), Haslam et al.
patent: 4599353 (1986-07-01), Bito
Bito Laszlo Z.
Stjernschantz Johan W.
Fay Zohreh A.
Robinson Douglas W.
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Use of a prostaglandin in combination with an adrenergic blockin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a prostaglandin in combination with an adrenergic blockin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a prostaglandin in combination with an adrenergic blockin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1590021